| Literature DB >> 22928084 |
Michalis G Nikolaidis1, Chad M Kerksick, Manfred Lamprecht, Steven R McAnulty.
Abstract
The detrimental outcomes associated with unregulated and excessive production of free radicals remains a physiological concern that has implications to health, medicine and performance. Available evidence suggests that physiological adaptations to exercise training can enhance the body's ability to quench free radicals and circumstantial evidence exists to suggest that key vitamins and nutrients may provide additional support to mitigate the untoward effects associated with increased free radical production. However, controversy has risen regarding the potential outcomes associated with vitamins C and E, two popular antioxidant nutrients. Recent evidence has been put forth suggesting that exogenous administration of these antioxidants may be harmful to performance making interpretations regarding the efficacy of antioxidants challenging. The available studies that employed both animal and human models provided conflicting outcomes regarding the efficacy of vitamin C and E supplementation, at least partly due to methodological differences in assessing oxidative stress and training adaptations. Based on the contradictory evidence regarding the effects of higher intakes of vitamin C and/or E on exercise performance and redox homeostasis, a permanent intake of non-physiological dosages of vitamin C and/or E cannot be recommended to healthy, exercising individuals.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22928084 PMCID: PMC3425865 DOI: 10.1155/2012/707941
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Basic study design characteristics of the studies investigated the effect of vitamin C and/or vitamin E supplementation on training adaptations.
| Study | Species | Number, sex, and age per group | Training state | Vitamin supplementation | Exercise protocol |
|---|---|---|---|---|---|
| Asha Devi et al. [ | Rat | 3 M (4, 8, 12, 22 m) | Untrained | Vit E (50 IU/kg bw/day) | Swimming (30 min, 5 sessions/week for 8.5 weeks) |
| Gomez-Cabrera et al. [ | Human | 5 M (29 y) or 9 M (31 y) | Untrained | Vit C (1000 mg/day) | Cycling (65−80% VO2 max, 3 sessions/week for 8 weeks) |
| Gomez-Cabrera et al. [ | Rat | 6 M (3 m) | Untrained | Vit C (500 mg/kg bw/day) | Running (75% VO2 max, 5 sessions/week for 3 or 6 weeks) |
| Higashida et al. [ | Rat | 3 M (3 m) or 6 M (3 m) | Untrained | Vit C (750 mg/kg bw/day) and vit E (150 mg/kg bw/day) | Swimming (6 h, 6 sessions/week for 3 days or 3 weeks) |
| Ristow et al. [ | Human | 10 M (26 y) | Untrained or moderately trained | Vit C (1000 mg/day) and vit E (400 IU/day) | Circuit training (65 min, 5 sessions/week for 4 weeks) |
| Roberts et al. [ | Human | 7 M (23) or 8 M (21) | Moderately trained | Vit C (1000 mg/day) | Interval running (50−90% VO2 max, 50 min, 4 sessions/week for 4 weeks) |
| Ryan et al. [ | Rat | 7 M (3 or 30 m) | Untrained | Vit C (20 g/kg bw/day) and vit E (30 g/kg bw/day) | Maximal stretch-shortening contractions |
| Theodorou et al. [ | Human | 14 M (26 y) | Moderately trained | Vit C (1000 mg/day) and vit E (400 IU/day) | Resistance training (75 maximal eccentric actions, 2 sessions/week for 4 months) |
| Yfanti et al. [ | Human | 10 M (31 y) or 11 M (29 y) | Moderately trained | Vit C (500 mg/day) and vit E (400 IU/day) | Cycling (40−85% VO2 max, 5 sessions/week for 12 weeks) |
Abbreviation: m: months; M: males; y: years.
Redox and physiological variables measured in the studies investigated the effect of vitamin C and/or vitamin E supplementation on training adaptations.
| Study | Vitamin | Redox biomarker | Training endpoint |
|---|---|---|---|
| Asha Devi et al. [ | Vit E (heart) | TBARS, catalase, SOD (heart) | Swimming time, plasma lipid profile |
| Gomez-Cabrera et al. [ | Vit C (plasma) | — | VO2 max |
| Gomez-Cabrera et al. [ | Vit C (plasma) | MnSOD, GPx (muscle) | Running time, cytochrome c |
| Higashida et al. [ | — | TBARS, MnSOD, CuZnSOD (muscle) | Mitochondrial proteins, GLUT4, glucose transport activity |
| Ristow et al. [ | — | TBARS (plasma and muscle), MnSOD, CuZnSOD, GPx1, catalase (muscle) | Insulin sensitivity |
| Roberts et al. [ | — | — | Various performance tests, substrate metabolism |
| Ryan et al. [ | — | Hydrogen peroxide, 8-OHdG, MDA, 4-hydroxyalkenals, GSH, GSSG, MnSOD, CuZnSOD, GPx, catalase (muscle) | Muscle hypertrophy, muscle function |
| Theodorou et al. [ | Vit C, vit E (plasma) | TBARS, protein carbonyls, GSH, GSSG, catalase, uric acid, albumin, bilirubin, TAC (plasma or erythrocytes) | Muscle performance, muscle damage |
| Yfanti et al. [ | Vit C, vit E (plasma) | MDA, protein carbonyls, MnSOD, CuZnSOD, GPx1, catalase, (muscle) | Body composition, VO2 max, power, insulin sensitivity, GLUT4 (muscle), glycogen (muscle), CS (muscle), HAD (muscle), lipid profile (plasma) |
Abbreviations: CS: citric synthase; CuZnSOD: copper zinc superoxide dismutase; GLUT4: glucose transporter type 4; GPx: glutathione peroxidase; GSH: glutathione; GSSG: glutathione disulfide; HAD: β-hydroxyacyl-CoA dehydrogenase; MDA: malondialdehyde; MnSOD: manganese superoxide dismutase; 8-OHdG: 8-hydroxy-2′-deoxyguanosine; SOD: superoxide dismutase; TAC: total antioxidant capacity; TBARS: thiobarbituric acid reactive substances.